
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 19, 2024, titled "Stock Exchange intimation on completion of USFDA inspection attransdermal manufacturing site".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 19, 2024, titled "Stock Exchange intimation on completion of USFDA inspection attransdermal manufacturing site".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences